Skip to main content
OpenTrials

Clinical trial condition

Neurodegenerative Diseases

Explore clinical trials studying Neurodegenerative Diseases. Study availability and eligibility vary by location and protocol.

9,035 public trials 1,770 recruiting studies
Refine in advanced search Browse all conditions

Neurodegenerative Diseases trial results

Completed

To Evaluate the Safety and Effectiveness of Atorvastatin Plus a Cholinesterase Inhibitor in AD Patients.

NCT00151502

Conditions
Alzheimer Disease, Alzheimer's Disease, Brain Diseases, +7 more
Locations
  • Pfizer Investigational Site Sun City, Arizona, United States
  • Pfizer Investigational Site Fresno, California, United States
  • Pfizer Investigational Site Laguna Hills, California, United States
  • Pfizer Investigational Site San Francisco, California, United States
View all 99 locations
View Trial Details
Completed

A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of TAK-935 (OV935) as an Adjunctive Therapy in Pediatric Participants With Developmental and/or Epileptic Encephalopathies

NCT03650452

Conditions
Brain Diseases, Brain Ischemia, CDKL5 deficiency disorder, +35 more
Locations
  • Phoenix Children's Hospital Phoenix, Arizona, United States
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Colorado Children's Hospital Aurora, Colorado, United States
  • Nicklaus Children's Hospital Miami, Florida, United States
View all 44 locations
View Trial Details
Completed

An Open-label Safety, Tolerability, and Dose-range Finding Study of Nusinersen (ISIS 396443) in Participants With Spinal Muscular Atrophy (SMA)

NCT01494701

Conditions
Central Nervous System Diseases, Motor Neuron Disease, Muscular Atrophy, Spinal, +5 more
Locations
  • Children's Hospital Boston Boston, Massachusetts, United States
  • Columbia University Medical Center New York, United States
  • UT Southwestern Medical Center - Children's Medical Center Dallas Dallas, Texas, United States
  • University of Utah School of Medicine Salt Lake City, Utah, United States
View Trial Details
Completed

A Efficacy, Safety and Pharmacokinetic Study of XP21279 and Sinemet® in Parkinson's Disease Subjects

NCT01171313

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +7 more
Locations
  • XenoPort Clinical Site Phoenix, Arizona, United States
  • XenoPort Clinical Site Little Rock, Arkansas, United States
  • XenoPort Clinical Site Long Beach, California, United States
  • XenoPort Clinical Site Sunnyvale, California, United States
View Trial Details
Completed

Feasibility - Infinitome

NCT04563767

Conditions
Alzheimer Disease, Brain Diseases, Central Nervous System Diseases, +6 more
Locations
  • HealthPartners Neuroscience Center Saint Paul, Minnesota, United States
View Trial Details

Related conditions